Announced Mon, 22 Jun · 16:35 IST
Independent Director Mr. Navin Kumar retires upon completing first term
Management Changes View source PDF
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+10.2%1-day move
₹168.19
prior close
₹175.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9+0.9+0.9+0.9+10.2+15.8+21.5+27.6+34.0+28.7+29.1+44.5——
Up moveDown movePending
AI summary
Bafna Pharmaceuticals announces the retirement of Mr. Navin Kumar (DIN: 08778662) as an Independent Director, effective close of business on June 22, 2026, upon completion of his first term. He also steps down as Chairman of the Audit Committee and the Nomination and Remuneration Committee. Mr. Palamadai Krishnan Sundaresan will take over as Chairman of both committees from June 23, 2026. The company confirms board composition remains compliant with applicable laws.
Likely market impact
Routine retirement at end of term. Board and committees remain compliant. No material impact expected on operations or governance.